NeuroPace Inc. (NPCE) reported its first-quarter 2025 earnings, surpassing expectations with an EPS of -$0.21 against a forecast of -$0.24. The company also posted a revenue of $22.5 million, exceeding the anticipated $21.85 million. Following the announcement,
Key Takeaways
- NeuroPace beat EPS expectations by $0.03, indicating improved financial performance.
- Revenue grew 24% year-over-year, driven by strong RNS system sales.
- Gross margin improved to 77%, up from 73.6% in the previous year.
- The stock rose 5.71% in aftermarket trading, reversing a 3.37% decline during regular hours.
- The company is focusing on expanding its RNS system and discontinuing SEEG product distribution.
Company Performance
NeuroPace demonstrated strong performance in Q1 2025, with significant revenue growth and improved financial metrics. The company’s RNS system sales increased by 26%, contributing to a 24% rise in total revenue compared to the same period last year.
Financial Highlights
- Revenue: $22.5 million, up 24% YoY
- Earnings per share: -$0.21, compared to a forecast of -$0.24
- Gross margin: 77%, an improvement from 73.6% in Q1 2024
- Net loss: $6.6 million, reduced from $8.9 million in Q1 2024
Earnings vs. Forecast
NeuroPace’s actual EPS of -$0.21 surpassed the forecasted -$0.24, resulting in a positive surprise of $0.03.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.